Charlotte's Web Holdings, Inc. (CWEB.TO)
- Previous Close
0.2250 - Open
0.2300 - Bid 0.2150 x --
- Ask 0.2300 x --
- Day's Range
0.2200 - 0.2300 - 52 Week Range
0.1800 - 0.6300 - Volume
5,071 - Avg. Volume
49,309 - Market Cap (intraday)
35.376M - Beta (5Y Monthly) 2.05
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2700 - Earnings Date Aug 8, 2024 - Aug 12, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.64
Charlotte's Web Holdings, Inc. is involved in the farming, manufacture, marketing, and sale of hemp-derived cannabidiol (CBD) wellness products. The company's products categories include hemp extract oil tinctures, such as liquid products; gummies; and capsules, CBD topical creams, and lotions, as well as products for pets under the Charlotte's Web, ReCreate, CBD Medic, CBD Clinic, and Harmony Hemp brands. Its products contain naturally occurring phytocannabinoids, including CBD, cannabichromene, cannabigerol, cannabinol, terpenes, flavonoids, and other beneficial hemp compounds. The company distributes its products through retail outlets and health care practitioners, as well as online through its website. It has a collaboration between its CW Labs science division and Colorado State University's College of Agricultural Sciences; and scientific collaboration with McLean Hospital. The company was formerly known as Stanley Brothers Holdings Inc. and changed its name to Charlotte's Web Holdings, Inc. in July 2018. The company was founded in 2013 and is headquartered in Louisville, Colorado.
www.charlottesweb.com164
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: CWEB.TO
Performance Overview: CWEB.TO
Trailing total returns as of 6/7/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CWEB.TO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CWEB.TO
Valuation Measures
Market Cap
35.38M
Enterprise Value
64.94M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.43
Price/Book (mrq)
0.55
Enterprise Value/Revenue
0.82
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-52.37%
Return on Assets (ttm)
-16.06%
Return on Equity (ttm)
-50.21%
Revenue (ttm)
58.27M
Net Income Avi to Common (ttm)
-30.52M
Diluted EPS (ttm)
-0.2700
Balance Sheet and Cash Flow
Total Cash (mrq)
38.51M
Total Debt/Equity (mrq)
128.86%
Levered Free Cash Flow (ttm)
-7.23M